Feed MRNA
MR
Moderna
MRNA · NASDAQ
$64.46 +0.33% (+$0.21)
1M +6.44%
Market Cap $25.6B
P/E Ratio -
Div. Yield -
ROE 32.45%
Piotroski F-Score Weak
2/9Valuation
34 /100
Fair P/S 13.16x
P/B 2.96x
P/E N/A
Growth
0 /100
Declining Rev. growth 53.13%
Book val. growth 23.24%
EPS growth N/A
Profitability
20 /100
Weak Gross margin 55.35%
Net margin 145.17%
FCF margin 106.22%
Quality
2 /100
Poor ROIC 30.28%
ROE 32.45%
Asset turnover 0.16x
Debt
100 /100
Low Debt/Equity 0.22x
Current ratio 3.29x
Int. coverage N/A
Stability
50 /100
Moderate Beta 0.90x
Rev. volatility 12.29%
Profitable years 0
Ρωτήστε το StockBot για MRNA
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Stéphane Bancel
Employees
4,700
Headquarters
Cambridge
Επερχόμενα γεγονότα
05 ΝΟΕ
Earnings
Upcoming earnings report